Institute of Cancer Research: New Strategy Targets "Undruggable" Protein in T-cell Leukaemia, Triggering Cancer Cell Death
January 30, 2026
January 30, 2026
LONDON, England, Jan. 30 -- The Institute of Cancer Research issued the following news on Jan. 29, 2026:
* * *
New strategy targets "undruggable" protein in T-cell leukaemia, triggering cancer cell death
Scientists have unveiled a ground-breaking approach to tackling one of cancer biology's most elusive targets: the protein LMO2, a key driver of T-cell acute lymphoblastic leukaemia (T ALL).
T ALL is a fast-growing cancer of the w . . .
* * *
New strategy targets "undruggable" protein in T-cell leukaemia, triggering cancer cell death
Scientists have unveiled a ground-breaking approach to tackling one of cancer biology's most elusive targets: the protein LMO2, a key driver of T-cell acute lymphoblastic leukaemia (T ALL).
T ALL is a fast-growing cancer of the w . . .